NASDAQ:NATRNature's Sunshine Products Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Nature's Sunshine Products Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $7.21 -0.41 (-5.38 %) (As of 04/3/2020 04:00 PM ET) Add Compare Share Today's Range$7.13Now: $7.21▼$7.6650-Day Range$6.11MA: $8.57▼$10.8552-Week Range$5.50Now: $7.21▼$10.85Volume13,382 shsAverage Volume19,735 shsMarket Capitalization$140.40 millionP/E Ratio20.60Dividend YieldN/ABeta0.66 ProfileAdvanced ChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Nature's Sunshine Products, Inc., a natural health and wellness company, primarily engages in the manufacture and sale of nutritional and personal care products worldwide. It operates through four segments: NSP Americas; NSP Russia; Central and Eastern Europe; and NSP China. The company offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. It also provides immunity, cardiovascular, and digestive products; and personal care products, including oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpastes, and skin cleansers, as well as weight management products. The company offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent managers and distributors. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Nature's Sunshine Products. Previous Next 2.3 Community Rank Outperform VotesNature's Sunshine Products has received 147 “outperform” votes. (Add your “outperform” vote.)Underperform VotesNature's Sunshine Products has received 172 “underperform” votes. (Add your “underperform” vote.)Community SentimentNature's Sunshine Products has received 53.92% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Nature's Sunshine Products and other stocks. Vote “Outperform” if you believe NATR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe NATR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldNature's Sunshine Products does not currently pay a dividend.Dividend GrowthNature's Sunshine Products does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nature's Sunshine Products insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 20.30% of the stock of Nature's Sunshine Products is held by insiders.Percentage Held by Institutions76.90% of the stock of Nature's Sunshine Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Nature's Sunshine Products is 20.60, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 11.23.Price to Earnings Ratio vs. SectorThe P/E ratio of Nature's Sunshine Products is 20.60, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 19.86.Price to Book Value per Share RatioNature's Sunshine Products has a P/B Ratio of 1.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.66 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryPersonal Products SectorMedical Current SymbolNASDAQ:NATR Previous Symbol CUSIP63902710 CIK275053 Webhttp://www.naturessunshine.com/ Phone801-341-7900Debt Debt-to-Equity Ratio0.16 Current Ratio1.95 Quick Ratio1.14Price-To-Earnings Trailing P/E Ratio20.60 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$362.21 million Price / Sales0.39 Cash Flow$0.97 per share Price / Cash Flow7.43 Book Value$6.70 per share Price / Book1.08Profitability EPS (Most Recent Fiscal Year)N/A Net Income$6.76 million Net Margins1.87% Return on Equity6.35% Return on Assets3.74%Miscellaneous Employees905 Outstanding Shares19,473,000Market Cap$140.40 million Next Earnings Date5/14/2020 (Estimated) OptionableNot Optionable Receive NATR News and Ratings via Email Sign-up to receive the latest news and ratings for NATR and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:NATR Rates by TradingView Nature's Sunshine Products (NASDAQ:NATR) Frequently Asked Questions How has Nature's Sunshine Products' stock been impacted by COVID-19 (Coronavirus)? Nature's Sunshine Products' stock was trading at $7.79 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NATR stock has decreased by 7.4% and is now trading at $7.21. View which stocks have been mosted impacted by Coronavirus. When is Nature's Sunshine Products' next earnings date? Nature's Sunshine Products is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Nature's Sunshine Products. How were Nature's Sunshine Products' earnings last quarter? Nature's Sunshine Products (NASDAQ:NATR) posted its quarterly earnings data on Wednesday, March, 11th. The company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $91.70 million for the quarter. Nature's Sunshine Products had a return on equity of 6.35% and a net margin of 1.87%. View Nature's Sunshine Products' earnings history. Has Nature's Sunshine Products been receiving favorable news coverage? News coverage about NATR stock has been trending very negative this week, according to InfoTrie. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Nature's Sunshine Products earned a coverage optimism score of -3.3 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutNature's Sunshine Products. Are investors shorting Nature's Sunshine Products? Nature's Sunshine Products saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 95,800 shares, an increase of 25.6% from the February 27th total of 76,300 shares. Based on an average daily volume of 21,300 shares, the short-interest ratio is currently 4.5 days. Currently, 0.6% of the shares of the stock are sold short. View Nature's Sunshine Products' Current Options Chain. Who are some of Nature's Sunshine Products' key competitors? Some companies that are related to Nature's Sunshine Products include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Avon Products (AVP), Prestige Consumer Healthcare (PBH), Inter Parfums (IPAR), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Medifast (MED), Revlon (REV) and Veru (VERU). What other stocks do shareholders of Nature's Sunshine Products own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nature's Sunshine Products investors own include Amicus Therapeutics (FOLD), AT&T (T), Catalyst Pharmaceuticals (CPRX), Gilead Sciences (GILD), AbbVie (ABBV), Bausch Health Companies (BHC), NovaBay Pharmaceuticals (NBY), Akorn (AKRX), Accelerate Diagnostics (AXDX) and Concert Pharmaceuticals (CNCE). Who are Nature's Sunshine Products' key executives? Nature's Sunshine Products' management team includes the following people: Mr. Terrence O. Moorehead, Pres, CEO & Director (Age 56)Mr. Joseph W. Baty, Exec. VP, CFO & Treasurer (Age 62)Ms. Susan M. Armstrong, Exec. VP & COO (Age 54)Ms. Adriana G. Mendizábal, Chief Marketing OfficerMr. Nathan G. Brower, Exec. VP, Gen. Counsel & Sec. (Age 39) What is Nature's Sunshine Products' stock symbol? Nature's Sunshine Products trades on the NASDAQ under the ticker symbol "NATR." How do I buy shares of Nature's Sunshine Products? Shares of NATR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Nature's Sunshine Products' stock price today? One share of NATR stock can currently be purchased for approximately $7.21. How big of a company is Nature's Sunshine Products? Nature's Sunshine Products has a market capitalization of $140.40 million and generates $362.21 million in revenue each year. Nature's Sunshine Products employs 905 workers across the globe. View additional information about Nature's Sunshine Products. What is Nature's Sunshine Products' official website? The official website for Nature's Sunshine Products is http://www.naturessunshine.com/. How can I contact Nature's Sunshine Products? Nature's Sunshine Products' mailing address is 2901 WEST BLUEGRASS BOULEVARD SUITE 100, LEHI UT, 84043. The company can be reached via phone at 801-341-7900 or via email at [email protected] This page was last updated on 4/3/2020 by MarketBeat.com StaffFeatured Article: What is the price-to-earnings growth (PEG) ratio?
